Microenvironment-dependent resistance to ABT-737 in chronic lymphocytic leukemia Response

被引：1
|
作者：
Butterworth, Michael [1 ]
Vogler, Meike [1 ]
Dyer, Martin J. S. [1 ]
Cohen, Gerald M. [1 ]
机构：
[1] Univ Leicester, MRC Toxicol Unit, Leicester LE1 9HN, Leics, England
来源：
BLOOD | 2009年 / 114卷 / 12期
关键词：
PROLIFERATION; INHIBITORS; APOPTOSIS; LYMPHOMA; BALANCE; CXCR4; CELLS;
D O I：
10.1182/blood-2009-07-232926
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2561 / 2562
页数：4
相关论文
共 50 条
  • [31] N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity
    S Bruno
    F Ghiotto
    C Tenca
    A N Mazzarello
    M Bono
    P Luzzi
    S Casciaro
    A Recchia
    A DeCensi
    F Morabito
    F Fais
    Leukemia, 2012, 26 : 2260 - 2268
  • [32] N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity
    Bruno, S.
    Ghiotto, F.
    Tenca, C.
    Mazzarello, A. N.
    Bono, M.
    Luzzi, P.
    Casciaro, S.
    Recchia, A.
    DeCensi, A.
    Morabito, F.
    Fais, F.
    LEUKEMIA, 2012, 26 (10) : 2260 - 2268
  • [33] A-1210477, a selective MCL-1 inhibitor, overcomes ABT-737 resistance in AML
    Wang, Qing
    Hao, Siguo
    ONCOLOGY LETTERS, 2019, 18 (05) : 5481 - 5489
  • [34] ABT-737 suppresses aberrant Hedgehog pathway and overcomes resistance to smoothened antagonists by blocking Gli
    Wenjing Huang
    Han Liu
    Wenfu Tan
    Juan Wang
    Medical Oncology, 39
  • [35] Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737
    Kutuk, Ozgur
    Letai, Anthony
    CANCER RESEARCH, 2008, 68 (19) : 7985 - 7994
  • [36] ABT-737 suppresses aberrant Hedgehog pathway and overcomes resistance to smoothened antagonists by blocking Gli
    Huang, Wenjing
    Liu, Han
    Tan, Wenfu
    Wang, Juan
    MEDICAL ONCOLOGY, 2022, 39 (12)
  • [37] ABT-737, Synergistically Enhances Daunorubicin-Mediated Apoptosis in Acute Myeloid Leukemia Cell Lines
    Dariushnejad, Hassan
    Zarghami, Nosratallah
    Rahmati, Mohammad
    Ghasemali, Samaneh
    Sadeghi, Zohreh
    Davoodi, Zahra
    Tekab, Hossein Jafari
    Ghalhar, Masoud Gandomkar
    ADVANCED PHARMACEUTICAL BULLETIN, 2014, 4 (02) : 185 - 189
  • [38] Inflammation, the microenvironment and chronic lymphocytic leukemia
    Caligaris-Cappio, Federico
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 353 - 355
  • [39] ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts
    Ugarenko, Michal
    Nudelman, Abraham
    Rephaeli, Ada
    Kimura, Ken-Ichi
    Phillips, Don R.
    Cutts, Suzanne M.
    BIOCHEMICAL PHARMACOLOGY, 2010, 79 (03) : 339 - 349
  • [40] The BCL-2 antagonist ABT-737 is highly effective on primary acute lymphoblastic leukemia cells
    Ricciardi, Maria Rosaria
    Gregorj, Chiara
    De Cave, Fabiana
    Bergamo, Paola
    Decandia, Samantha
    Santinelli, Ara
    Vitale, Antonella
    Petrucci, Maria Teresa
    Milella, Michele
    Foa, Robert
    Tafuri, Agostino
    BLOOD, 2007, 110 (11) : 53A - 53A
12345